Full-text resources of CEJSH and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

PL EN


2023 | 36 | 5 | 685-692

Article title

Acute mercuric chloride poisoning at a potentially lethal dose ended with survival: symptoms, concentration in cerebrospinal fluid, treatment

Content

Title variants

Languages of publication

Abstracts

EN
This study aims to present a case of acute mercuric chloride poisoning at a potentially lethal dose treated with the antidote – 2,3-dimercapto- 1-propanesulfonic acid (DMPS) and continuous renal replacement therapy (CRRT) combined with CytoSorb. A 21-year-old woman was admitted to a hospital with abdominal pain, vomiting, and suspected gastrointestinal bleeding after taking 5000 mg of mercuric chloride for suicidal purposes. Due to the patient deteriorating general condition and multiple organ damage, on the third day she was transported to the Clinic of Anaesthesiology and Intensive Care (CAaIC), Łódź, Poland. Laboratory tests confirmed features of acute kidney injury and high mercury levels in the blood (1051 μg/l) and urine (22 960 μg/l) – DMPS therapy and CRRT combined with CytoSorb were instituted. Due to nervous system complaints (headache, dizziness), a lumbosacral puncture was performed – the mercury concentration in the cerebrospinal fluid (CSF) was 5.45 μg/l. During a colonoscopy, significant diagnostic abnormalities revealed features of colonic mucosal necrosis. The treatment resulted in a decrease in subjective complaints, decreased mercury levels in biological material, and improved parenchymal organ function. On the 15th day of therapy, the patient was transferred to the primary care center for further treatment. The case confirms the possibility of improvement of patient condition following ingestion of a potentially lethal dose (5 g) as a result of the initiation of appropriate therapy even on the third day. The presence of mercury in CSF confirms that inorganic mercury compounds (mercuric chloride) can pass through the blood-brain barrier after oral ingestion.

Year

Volume

36

Issue

5

Pages

685-692

Physical description

Dates

published
2023

Contributors

  • Central Clinical Hospital of the Medical University of Łódź, Łódź, Poland (Clinic of Anaesthesiology and Intensive Care)
  • Nofer Institute of Occupational Medicine, Łódź, Poland (Centre for Physicians Training in Public Health)
author
  • Nofer Institute of Occupational Medicine, Łódź, Poland (Department of Biological and Environmental Monitoring)
  • Central Clinical Hospital of the Medical University of Łódź, Łódź, Poland (Clinic of Anaesthesiology and Intensive Care)
  • Medical University of Łódź, Łódź, Poland (Department of Laboratory Diagnostics and Clinical Biochemistry)
  • Central Clinical Hospital of Medical University of Łódź, Łódź, Poland (Medical Diagnostic Laboratory)
  • Central Clinical Hospital of the Medical University of Łódź, Łódź, Poland (Clinic of Anaesthesiology and Intensive Care)

References

Document Type

Publication order reference

Identifiers

Biblioteka Nauki
21375385

YADDA identifier

bwmeta1.element.ojs-doi-10_13075_ijomeh_1896_02235
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.